Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Rani Therapeutics Holdings (RANI) Leases (2022 - 2025)

Rani Therapeutics Holdings has reported Leases over the past 4 years, most recently at $4.3 million for Q4 2025.

  • Quarterly results put Leases at $4.3 million for Q4 2025, down 15.27% from a year ago — trailing twelve months through Dec 2025 was $4.3 million (down 15.27% YoY), and the annual figure for FY2025 was $4.3 million, down 15.27%.
  • Leases for Q4 2025 was $4.3 million at Rani Therapeutics Holdings, up from $4.0 million in the prior quarter.
  • Over the last five years, Leases for RANI hit a ceiling of $6.0 million in Q1 2024 and a floor of $718000.0 in Q4 2023.
  • Median Leases over the past 4 years was $2.7 million (2023), compared with a mean of $3.0 million.
  • Biggest five-year swings in Leases: plummeted 32.58% in 2023 and later skyrocketed 609.75% in 2024.
  • Rani Therapeutics Holdings' Leases stood at $1.1 million in 2022, then plummeted by 32.58% to $718000.0 in 2023, then skyrocketed by 609.75% to $5.1 million in 2024, then decreased by 15.27% to $4.3 million in 2025.
  • The last three reported values for Leases were $4.3 million (Q4 2025), $4.0 million (Q3 2025), and $4.4 million (Q2 2025) per Business Quant data.